These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8176883

  • 1. Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury.
    Camussi G.
    Lab Invest; 1994 Apr; 70(4):435-6. PubMed ID: 8176883
    [No Abstract] [Full Text] [Related]

  • 2. Receptor antagonists of platelet-activating factor do not influence the development of passive Heymann nephritis.
    Salvidio G, Brentjens J, Camussi G.
    J Lipid Mediat; 1991 Apr; 3(2):197-204. PubMed ID: 1665716
    [Abstract] [Full Text] [Related]

  • 3. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis.
    Livio M, Macconi D, Morigi M, Orisio S, Benigni A, Patrono C, Remuzzi G.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Apr; 17B():828-32. PubMed ID: 2823570
    [No Abstract] [Full Text] [Related]

  • 4. Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury.
    Prescott SM, McIntyre TM, Zimmerman G.
    J Clin Invest; 1999 Oct; 104(8):1019-20. PubMed ID: 10525039
    [No Abstract] [Full Text] [Related]

  • 5. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.
    Kulikov VI, Muzya GI.
    Biochemistry (Mosc); 1998 Jan; 63(1):47-54. PubMed ID: 9526094
    [Abstract] [Full Text] [Related]

  • 6. [Effects of platelet activating factor on blood platelets].
    Fu JM.
    Sheng Li Ke Xue Jin Zhan; 1989 Jan; 20(1):40-4. PubMed ID: 2549618
    [No Abstract] [Full Text] [Related]

  • 7. [Function of platelet activating factor in asthma].
    Ukena D, Sybrecht GW.
    Dtsch Med Wochenschr; 1988 Oct 21; 113(42):1651-6. PubMed ID: 2846251
    [No Abstract] [Full Text] [Related]

  • 8. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M, Guinot P, Hosford D, Braquet PG.
    Adv Pharmacol; 1994 Oct 21; 28():81-167. PubMed ID: 8080821
    [No Abstract] [Full Text] [Related]

  • 9. [Progress in platelet-activating factor receptor research].
    Hu GL, Guo HS.
    Sheng Li Ke Xue Jin Zhan; 1997 Jan 21; 28(1):83-4. PubMed ID: 10921090
    [No Abstract] [Full Text] [Related]

  • 10. [Study of platelet activating factor by using mouse ontogenic technology].
    Kume K, Shimizu K, Ishii S.
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec 21; 19(6):572-5. PubMed ID: 9081720
    [No Abstract] [Full Text] [Related]

  • 11. [The significance of platelet activating factor and its antagonists in bronchial asthma].
    Beume R, Kilian U.
    Med Klin (Munich); 1989 Jun 15; 84(6):286-93. PubMed ID: 2547143
    [No Abstract] [Full Text] [Related]

  • 12. Effect of platelet-activating factor on platelets and vascular endothelium.
    Braquet P, Bourgain R, Mencia-Huerta JM.
    Semin Thromb Hemost; 1989 Apr 15; 15(2):184-96. PubMed ID: 2546255
    [No Abstract] [Full Text] [Related]

  • 13. [The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage].
    Egido J, Gómez-Chiarri M, Lerma JL, González E, Maestre C, Ortiz A, Hernando L.
    Rev Clin Esp; 1990 Apr 15; 187(3):137-43. PubMed ID: 2284487
    [No Abstract] [Full Text] [Related]

  • 14. Chemotactic mediator requirements in lung injury following skin burns in rats.
    Piccolo MT, Wang Y, Sannomiya P, Piccolo NS, Piccolo MS, Hugli TE, Ward PA, Till GO.
    Exp Mol Pathol; 1999 Aug 15; 66(3):220-6. PubMed ID: 10486240
    [Abstract] [Full Text] [Related]

  • 15. [Platelet activating factor].
    Deguchi K, Murashima S, Deguchi A.
    Nihon Rinsho; 1987 May 15; 45(5):1115-26. PubMed ID: 3041069
    [No Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor (PAF) and blastocyst-endometrial interactions.
    Harper MJ, Kudolo GB, Alecozay AA, Jones MA.
    Prog Clin Biol Res; 1989 May 15; 294():305-15. PubMed ID: 2542988
    [No Abstract] [Full Text] [Related]

  • 17. [Platelet-activating factor (PAF) receptor-related pathophysiology].
    Ishii S, Shimizu T.
    Tanpakushitsu Kakusan Koso; 1999 Jun 15; 44(8 Suppl):1068-74. PubMed ID: 10396985
    [No Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W, Lang D, Hawes AS, Zelano JA, Isom OW, Krieger KH.
    J Surg Res; 1993 Nov 15; 55(5):504-15. PubMed ID: 8231170
    [Abstract] [Full Text] [Related]

  • 19. [Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system].
    Shebzukhov IuV, Mysiakin EB.
    Vopr Med Khim; 1996 Nov 15; 42(4):278-83. PubMed ID: 9254510
    [Abstract] [Full Text] [Related]

  • 20. Interspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist.
    Elder CA, Modi MW.
    Drug Metab Dispos; 1995 Jul 15; 23(7):776-8. PubMed ID: 7587967
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.